Neuropathix, Inc. | Breakthrough Therapeutics Targeting Inflammation
Doylestown, PA
Joined July 2020
- Tweets80
- Following84
- Followers88
- Likes111
Pinned Tweet
@Neuropathix subsidiary @Kannalife Awarded $2.97 Million Grant from National Institute of Neurological Disorders and Stroke (NINDS)
$NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch #PainMonth2021
finance.yahoo.com/news/neuro…
Exciting news! Join @Neuropathix CEO Dean Petkanas at the 7th CB1, CB2, & Cannabinoid Drug Development Summit in Boston, Nov 18-20!
Don’t miss insights on #Cannabinoids #PeripheralNeuropathy #Neuroscience #MedicalResearch #Innovation #GPCR #GPR55 #CIPN
cannabinoid-derived-drug-dev…
Join @neuropathix CEO Dean Petkanas at the 7th CB1, CB2, & Cannabinoid Drug Development Summit November 18-20, 2024 | Boston, MA hosted by @HansonWade
#kannalife #gpcr #gpr55 #nlrp3 #ncx1 #kls13019 #neuro #inflammation #mitochondria
cannabinoid-derived-drug-dev…
Neuropathix retweeted
1,4 Mio € von @MichaelJFoxOrg für Chi Wang Ip @Uniklinikum_Wue & Partnern @Kannalife #Atuka. Sie untersuchen am spez. Mausmodell, ob KLS-13019, das strukturell mit Cannabinoiden verwandt ist, ein wirksames Medikament gegen #Parkinson sein könnte.
nachrichten.idw-online.de/20…
Neuropathix retweeted
@Kannalife featured in @parkinsonstory - @MichaelJFoxOrg $1.49M grant to advance preclinical research into #KLS13019 - #Parkinsons #ParkinsonsResearch #Neuroinflammation #MitochondrialDysfunction #CannabinoidTherapeutic #Kannalife #MJFF
parkinsonsnewstoday.com/news…
Neuropathix retweeted
@Kannalife secures $1.49M from @MichaelJFoxOrg for #ParkinsonsResearch! This funding will boost the development of #KLS13019, addressing #neuroinflammation and #mitochondrialdysfunction.
#Biotech #Innovation #CannabinoidTherapeutics #Kannalife #MJFF
globenewswire.com/news-relea…
Neuropathix retweeted
@Kannlife CEO Dean Petkanas interview at @IAmBiotech #BIO2024 by Life Science Success Podcast #neuroprotection #cannabinoidtherapeutics #nlrp3 #gpcr #gpr55 #mitochondria #ncx1 #antiinflammatory
youtube.com/watch?v=MB_YtMrn…
Neuropathix retweeted
@Kannalife selected by @NIH as one of 30 Companies to present at @BIOConvention in San Diego. Presentation Tues June 4, 2024 @ 4:30 PM in Company Presentation Theater 3. Plus visit us NIH booth #825 on Tues June 4 @ 11:56 AM #BIO #NIH #Kannalife #Biotech
convention.bio.org/speakers/…
ALT @Kannalife selected by @NIH as one of 30 Companies to present at @BIOConvention in San Diego. Presentation Tues June 4, 2024 @ 4:30 PM in Company Presentation Theater 3. Plus visit us NIH booth #825 on Tues June 4 @ 11:56 AM #BIO #NIH #Kannalife #Biotech https://convention.bio.org/speakers/dean-petkanas
Exciting times @BioNJ_Org 🧬 Dean Petkanas of @Neuropathix @Kannalife sees New Jersey as the ultimate hub for life sciences. With 50% of attendees agreeing, NJ proves it's a leader in biotech! @ROINJNews #BioNJ #LifeSciences #Biotech #Pharma #Innovation
roi-nj.com/2024/05/15/opinio…
Neuropathix retweeted
@Kannalife #Research Alert! Uncovering link between #KLS13019 & #GPR55 receptor - promising role in reducing #inflammation from chemotherapy-induced #peripheralneuropathy.
#Cannabinoid #Innovation #GPCR #CIPN #NeuroPain #Mitochondria
rdcu.be/dFqru
Dean Petkanas CEO of @Neuropathix @Kannalife presenting “#KLS13019 - A Remarkable #NonOpioid Drug Discovery for the #Treatment of #NeuroPain” -
Tune in on April 2, 2024 @ 11:30am EST / 8:30am PST - us02web.zoom.us/j/8854923699…
Join @Neuropathix at the 2023 @LifeSciSummit by @NIH on Oct 11, 2023 and see our subsidiary @Kannalife selected to take the stage at the Alexandria Center for Life Science in NYC
Learn more: lifesciencessummit.org/prese…
#Kannalife #Neuropathix #LifeSciSummit #Biotech #Innovation
Today is the 12 year anniversary of founding @Neuropathix subsidiary @kannalife.
$NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch #pain #nonopioid #opioidalternative #cannabidiol #cbd
youtube.com/watch?v=cTtD03mp…
@Neuropathix CEO Dean Petkanas pens Op-Ed on Why Opioids controlled the Pain Management Market and What's Next.
$NPTX #NPTX #Neuropathix #KLS13019 #Kannalife #opioids #opioidcrisis #pain #painmanagement #nonopioids #NIH #NINDS #HEALInitiative
nasdaq.com/articles/why-opio…
@Neuropathix Highlights Revenue Related to its Grant Award with NIH-NINDS
$NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch #pain #nonopioid #opioidalternative #cannabidiol #cbd
finance.yahoo.com/news/neuro…
@Neuropathix Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019
$NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch #pain #nonopioid #opioidalternative #cannabidiol #cbd
finance.yahoo.com/news/neuro…
@Neuropathix CEO Issues New Letter to Shareholders; Updates Market on Milestones in Research and Funding
$NPTX #NPTX #Neuropathix #Kannalife #KLS13019 #Grant #NIH #NINDS #HEALInitiative #SpotlightOnPainResearch
finance.yahoo.com/news/neuro…
.@Neuropathix spokesman and former #NFL Kicker Nick Lowery discusses the need for #opioidalternatives for #pain.
$NPTX #NPTX #Neuropathix #kannalife #opioid #opioids #opioidepidemic #nonopioid #kls13019 #cannabinoids #cannabidiol #chronicpain
fox5sandiego.com/sports/ucsd…